Comparison of Presentation and Prognosis of Takayasu Arteritis with or without Stroke or Transient Ischemic Attack—A Retrospective Cohort Study
Authors:
- Durga Prasanna MisraDurga Prasanna Misra
- Upendra RathoreURUpendra Rathore
- Prabhaker MishraPMPrabhaker Mishra
- Kritika SinghKSKritika Singh
- Darpan R. ThakareDTDarpan R. Thakare
- Manas Ranjan BeheraMBManas Ranjan Behera
- Neeraj JainNJNeeraj Jain
- Manish OraMOManish Ora
- Dharmendra Singh BhadauriaDBDharmendra Singh Bhadauria
- Sanjay GambhirSGSanjay Gambhir
- Sudeep KumarSKSudeep Kumar
- Vikas AgarwalVAVikas Agarwal
Open Access
Abstract
Takayasu arteritis (TAK) could cause a stroke or transient ischemic attack (TIA) in young individuals due to inflammatory vascular occlusion or intracerebral hemorrhage. We compared the clinical presentation, angiographic features, longitudinal patterns of disease activity, medical treatments, and survival in 34 TAK patients with stroke/TIA and 157 without stroke/TIA from a single-center retrospective cohort. TAK patients with stroke/TIA were older (p = 0.044) with a greater proportion of males (p = 0.022), more frequent vision loss (odds ratio (OR) for stroke/TIA vs. without stroke TIA 5.21, 95% CI 1.42–19.14), and less frequent pulse or blood pressure inequality (OR 0.43, 95% CI 0.19–0.96) than TAK patients without stroke/TIA. Hata’s angiographic type IIa was more common in TAK patients with stroke/TIA (OR 11.00, 95%CI 2.60–46.58) and type V in TAK patients without stroke/TIA (OR 0.27, 95% CI 0.12–0.58). Cyclophosphamide was used more often in TAK patients with stroke/TIA (p = 0.018). Disease activity at baseline, 6, 12, and 24 months of follow-up was mostly similar for both groups. Risk of mortality was similar in TAK patients with or without stroke/TIA (hazard ratio unadjusted 0.76, 95% CI 0.15–3.99; adjusted for gender, age of disease onset, delay to diagnosis, baseline disease activity, and the number of conventional or biologic/targeted synthetic immunosuppressants used 1.38, 95% CI 0.19–10.20) even after propensity score-matched analyses. Stroke or TIA does not appear to affect survival in TAK patients adversely.Keywords
Funding Information
- Indian Council of Medical Research (3/1/1(20)/2022-NCD-I)
This publication has 69 references indexed in Scilit:
- Ischemic Stroke in Takayasu's Arteritis: Lesion Patterns and Possible MechanismsJournal of Clinical Neurology, 2012
- Disease progression after initial surgical intervention for Takayasu arteritisJournal of Vascular Surgery, 2011
- Bias Formulas for Sensitivity Analysis of Unmeasured Confounding for General Outcomes, Treatments, and ConfoundersEpidemiology, 2011
- Assessment of disease activity and progression in Takayasu’s arteritis with Disease Extent Index-TakayasuRheumatology, 2010
- EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteriaAnnals of the Rheumatic Diseases, 2010
- Takayasu Arteritis in FranceMedicine, 2010
- Takayasu’s arteritis: Operative results and influence of disease activityJournal of Vascular Surgery, 2006
- Cerebrovascular manifestations of Takayasu arteritis in EuropeRheumatology, 2005
- Takayasu arteritis: lessons from the American National Institutes of Health experienceInternational Journal of Cardiology, 1996
- The American College of Rheumatology 1990 criteria for the classification of takayasu arteritisArthritis & Rheumatism, 1990